Company Number: 12705948

Analysis Date: 2025-07-29 16:57 UTC

Financial Health Assessment: VALUEPRO ACCOUNTING LIMITED

---

1. Financial Health Score: D

Explanation:
The company currently exhibits significant financial distress, indicated by persistent net liabilities and negative working capital. The trend over recent years shows worsening liquidity and solvency, which are critical "vital signs" of financial health. This score reflects a need for urgent attention to restore stability.

---

2. Key Vital Signs

Metric	Latest Value (2024)	Interpretation
Current Assets	£100	Extremely low cash or liquid assets, insufficient for daily operations.
Current Liabilities	£5,696	Short-term debts due within a year that far exceed current assets.
Net Current Assets (Working Capital)	(£5,596)	Negative working capital indicates inability to meet short-term obligations ("symptom of distress").
Net Assets (Shareholders' Funds)	(£5,596)	Negative equity signals accumulated losses or liabilities exceeding assets; financial health is poor.
Share Capital	£100	Minimal equity investment; limited cushion for absorbing losses.
Trend Analysis	Deteriorating	Net liabilities have increased from (£3,172) in 2023 to (£5,596) in 2024, showing worsening position.

---

3. Diagnosis

• Liquidity Crisis: The company lacks healthy cash flow or liquid assets to cover its immediate liabilities. This is akin to a patient with dangerously low blood pressure — urgent intervention is necessary to avoid collapse.
• Solvency Concerns: Negative net assets reflect that total liabilities exceed total assets. This chronic condition implies the company may be insolvent on a balance sheet basis.
• Operational Status: No employees and minimal assets suggest the company might be dormant or minimally active, raising questions about ongoing operational viability.
• Ownership and Control: The single director and shareholder holds full control, which can expedite decision-making but also concentrates risk.
• Name Changes: Multiple recent name changes could indicate attempts at restructuring or rebranding, possibly reflecting strategic uncertainty or attempts to reset market perception.

---

4. Recommendations

1. Immediate Cash Flow Management:

   • Seek short-term funding or injection of capital to cover current liabilities and restore working capital.
   • Negotiate with creditors to restructure or extend payment terms ("stabilize the patient").

2. Strategic Review:

   • Assess the business model and revenue-generating activities to identify root causes of losses.
   • Consider whether the company should pivot, downsize, or wind down operations if recovery is unfeasible.

3. Equity Injection or Debt Restructuring:

   • Explore options for additional equity investment to bolster shareholders’ funds.
   • Alternatively, negotiate debt restructuring to reduce liabilities.

4. Operational Activity Assessment:

   • Confirm whether the company is actively trading or dormant in practice. If dormant, formalize status to reduce ongoing costs and compliance burden.

5. Financial Monitoring and Reporting:

   • Implement tighter financial controls and regular monitoring to detect early warning signs.
   • Prepare detailed forecasts and cash flow projections to guide decisions.

---

Medical Analogy Summary

VALUEPRO ACCOUNTING LIMITED is currently exhibiting "symptoms of financial distress," akin to a patient with low vital signs—specifically, poor liquidity and solvency. Without timely intervention—such as capital infusion or strategic restructuring—the prognosis is guarded, with a risk of financial "collapse" or insolvency.

---